Matthew Winton - 13 Mar 2024 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
COO
Signature
/s/ Matthew Winton
Issuer symbol
INZY
Transactions as of
13 Mar 2024
Net transactions value
$0
Form type
4
Filing time
15 Mar 2024, 08:30:09 UTC
Previous filing
04 Apr 2023
Next filing
03 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INZY Stock Option (right to buy) Award $0 +175,000 $0.000000 175,000 13 Mar 2024 Common Stock 175,000 $5.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on March 13, 2024 and is scheduled to vest in equal monthly installments until the fourth anniversary of the grant date.